Boiron SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boiron SA with three other
companies in this sector in France:
sales of 852.62 million Euro [US$902.25 million]
of which 56%
was Companion Animals),
(488.74 million Euro [US$517.18 million]
of which 43%
was X-rays), and
(342.61 million Euro [US$362.55 million]
of which 60%
was Operating Segment - Europe).
During the year ended December of 2015, sales at
Boiron SA were 607.80 million Euro (US$643.18 million).
decrease of 0.3%
versus 2014, when the company's sales were 609.75 million Euro.
Contributing to the drop in overall sales was the 81.2% decline
in Other, from 1.57 million Euro to 294,000.00 Euro.
There were also decreases in sales in
Otc Specialities and Other Products (down 2.2% to 296.95 million Euro)
However, these declines were partially offset by the increase in sales of
Non-Proprietary Homeopathic Medicines (up 1.7% to 310.56 million Euro)